SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-007542
Filing Date
2019-05-15
Accepted
2019-05-15 17:22:37
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 891235
2 ex31-1.htm EX-31.1 18406
3 ex31-2.htm EX-31.2 18516
4 ex32-1.htm EX-32.1 10065
  Complete submission text file 0001493152-19-007542.txt   5713556

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE obmp-20190331.xml EX-101.INS 982396
6 XBRL SCHEMA FILE obmp-20190331.xsd EX-101.SCH 65242
7 XBRL CALCULATION FILE obmp-20190331_cal.xml EX-101.CAL 57908
8 XBRL DEFINITION FILE obmp-20190331_def.xml EX-101.DEF 259646
9 XBRL LABEL FILE obmp-20190331_lab.xml EX-101.LAB 451217
10 XBRL PRESENTATION FILE obmp-20190331_pre.xml EX-101.PRE 350385
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 19829719
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences